HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

3rd Edition of International Heart Congress

June 05-07,2025 | Hybrid Event

June 05 -07, 2025 | Rome, Italy

Heart Congress 2025

Miroslav Radenkovic, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Miroslav Radenkovic, University of Belgrade, Serbia

Pulmonary arterial hypertension (PAH) remains a debilitating disease with high morbidity and mortality. It is a rare, progressive and ultimately life-threatening disease in which blood vessels in the lungs thicken and narrow, causing significant strain on the heart. Patients with [....] » Read More

Narendra Kumar, Speaker at Heart Congress
Keynote Presentation (In-Person)
Narendra Kumar, HeartbeatsZ Academy, United Kingdom

Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting millions worldwide. While catheter ablation is a well-established treatment for AF, it carries risks of complications such as pulmonary vein stenosis (PVS) and esophageal injury. Pulse field ablation (PF [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Sergey Suchkov, The Russian University of Medicine, Russian Federation

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, Personalized and Precision Medicine (PPM). To achieve the implementation of PPM concept, it is necessary to create a fundamentally new strategy based upon the recogni [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Sergey Suchkov, The Russian University of Medicine, Russian Federation

Catalytic Abs (catAbs) are multivalent immunoglobulins (Igs) with a capacity to hydrolyze the antigenic (Ag) substrate. In this sense, proteolytic Abs (Ab-proteases) represent Abs to provide proteolytic effects. Abs against Cardiac Myosin (CM) with proteolytic activity exhibiting [....] » Read More

Iris Panagiota Efthymiou, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom

Effective communication is at the heart of quality patient care, especially in cardiology, where complex medical decisions can significantly impact patient outcomes. This speech addresses the critical role of communication between cardiologists and patients in enhancing cardiac c [....] » Read More

Desislava Doycheva, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
Desislava Doycheva, Loma Linda University, United States

Cardiovascular diseases, particularly myocardial infarction (MI), remain a major global health challenge. Recent studies have highlighted the cardioprotective potential of sodium-glucose co-transporter 2 (SGLT2) inhibitors, originally developed for managing glycemia in diabetes. [....] » Read More

Barbara Ribeiro de Oliveira Mendes, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Barbara Ribeiro de Oliveira Mendes, INSERM, France

Long QT syndrome type 2 (LQTS2) is a potentially fatal cardiac arrhythmia disorder, often resulting from rare loss-of-function variations in the KCNH2 gene, encoding the hERG cardiac channel. The identification of hERG variants is essential for diagnosing LQTS2 and providing appr [....] » Read More

Ali Mohammadpour, Speaker at Heart Conferences
Oral Presentation (In-Person)
Ali Mohammadpour, Gonabad University of Medical Sciences, Iran (Islamic Republic of)

Introduction: Chest pain is a common complaint in patients with acute coronary syndrome(ACS). Pharmacological pain management is associated with different side effects. This study aimed to determine the effect of local heat therapy on the chest pain in patients with ACS. [....] » Read More

Shibikom Tamirat, Speaker at Heart Conferences
Oral Presentation (In-Person)
Shibikom Tamirat, Childrens’ Heart Fund of Ethiopia, Ethiopia

With the advent of interventional cardiology service in Ethiopia, there is increasing number of pacemaker pocket infection. In principle, pacemaker pocket infection shoud be managed with explantation of the generator and the leads as well. Then the patient will be kept on tempora [....] » Read More

Hattab Oumayma, Speaker at Heart Conferences
Oral Presentation (In-Person)
Hattab Oumayma, Centre Hospitalier Universitaire Mohammed VI, Morocco

Introduction: It is a well-knowned that important differences in heart failure patient with reduced ejection fraction (HFrEF) exist between men and women. However, the impact of gender on mortality in this category of patients has not been sufficiently studied. Purpose:&n [....] » Read More

Getu Debalkie Demissie, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Getu Debalkie Demissie, Baker Heart and Diabetes Institute and La Trobe University, Australia

Background: Studies have demonstrated the short-term effectiveness of structured lifestyle interventions in lowering absolute cardiovascular disease (CVD) risk among individuals at high risk for type 2 diabetes. However, their long-term impact remains unclear. Objective: This [....] » Read More

Yoandy Lopez de la Cruz, Speaker at Cardiovascular Conference
Poster Presentation (In-Person)
Yoandy Lopez de la Cruz, Ministry of Public Health, Cuba

Internal thoracic artery (ITA) harvesting is an important surgical procedure in cardiovascular surgery. In recent decades, more and more patients are revascularized with grafts from both internal thoracic arteries, which has shown better long-term outcomes. Since Favaloro introdu [....] » Read More

Abhishek Chandra, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Abhishek Chandra, Abbott Northwestern Hospital, United States

Background: Direct-acting oral anticoagulants (DOACs) are absorbed in the upper gastrointestinal tract, but patients with gastrointestinal disease were not included in the Phase II and III drug investigations. This report details a patient with altered gastrointestinal anatomy an [....] » Read More

Joao Rafael Rocha Da Silva, Speaker at Heart Conferences
Oral Presentation (Virtual)
Joao Rafael Rocha Da Silva, Connect Life Rehabilitation And Performance, Brazil

Chronic pain is defined as persistent pain for more than three months and can be classified as primary with no known etiology, or secondary pertinent to a pathological process and specific clinical diagnosis. In previous studies, we observed that it directly impacts cardiac rehab [....] » Read More

Cristina Milagre Quadros Borges, Speaker at Heart Conferences
Oral Presentation (Virtual)
Cristina Milagre Quadros Borges, Hcor- Heart Hospital of Sao Paulo, Brazil, Brazil

Cardiovascular diseases (CVD) correspond to the main cause of death worldwide in both sexes. 1/3 of deaths from all causes affects men and women in all age groups. They represent more than bouble the number of deaths from all neoplas associated. Increase in the prevalence of CVD [....] » Read More

Nilay Solanki, Speaker at Charotar University of Science and Technology
Oral Presentation (Virtual)
Nilay Solanki, Charotar University of Science and Technology, India

Background: Coronary artery disease (CAD) results from the obstruction of blood supply to the heart. Angioplasty is a common intervention for managing CAD, supplemented by supportive and preventive therapies. Modifiable risk factors for CAD include hypertension, diabetes, dy [....] » Read More

Yasser Mohammed Hassanain Elsayed, Speaker at Heart Conferences
Oral Presentation (Virtual)
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt

Introduction: Atrial fibrillation (AF) is one of the most common and probable serious arrhythmia and a hallmark of an increasing risk of pathological thrombus formation. Interestingly, normal sinus rhythm (NSR) is the standard rhythm in a normal person. The sino-atrial node (SAN) [....] » Read More

Will be updated soon......
Watsapp